Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Total Debt (2016 - 2020)

Historic Total Debt for Larimar Therapeutics (LRMR) over the last 7 years, with Q1 2020 value amounting to $6.7 million.

  • Larimar Therapeutics' Total Debt fell 5011.83% to $6.7 million in Q1 2020 from the same period last year, while for Mar 2020 it was $6.7 million, marking a year-over-year decrease of 5011.83%. This contributed to the annual value of $8.5 million for FY2019, which is 4426.08% down from last year.
  • Latest data reveals that Larimar Therapeutics reported Total Debt of $6.7 million as of Q1 2020, which was down 5011.83% from $8.5 million recorded in Q4 2019.
  • Larimar Therapeutics' 5-year Total Debt high stood at $20.2 million for Q1 2018, and its period low was $1.2 million during Q3 2016.
  • Moreover, its 5-year median value for Total Debt was $11.9 million (2019), whereas its average is $11.3 million.
  • Per our database at Business Quant, Larimar Therapeutics' Total Debt plummeted by 7116.77% in 2016 and then crashed by 2407.5% in 2018.
  • Quarter analysis of 5 years shows Larimar Therapeutics' Total Debt stood at $1.2 million in 2016, then soared by 1566.67% to $20.0 million in 2017, then dropped by 24.08% to $15.2 million in 2018, then crashed by 44.26% to $8.5 million in 2019, then fell by 20.29% to $6.7 million in 2020.
  • Its Total Debt stands at $6.7 million for Q1 2020, versus $8.5 million for Q4 2019 and $10.2 million for Q3 2019.